The short answer
Gimble and colleagues published on delta sleep-inducing peptide and glucocorticoid-induced leucine zipper as potential links between circadian mechanisms and obesity in Obesity Reviews in 2009. The title ends in a question mark, which accurately describes what is being proposed.
Key facts
- Study
- Gimble 2009 (PMID 19849801)
- Journal
- Obes Rev, November 2009
- Other molecule
- GILZ (glucocorticoid-induced leucine zipper)
- Proposed link
- Circadian mechanisms and obesity
- Article type
- Hypothesis, framed as a question
- Common thread
- Glucocorticoid regulation
Why DSIP appears in an obesity journal at all
Because the proposed connection runs through glucocorticoids and circadian timing rather than through sleep. Cortisol follows a strong daily rhythm, influences adipose biology, and connects to metabolic regulation. A substance tracking that axis has a route into obesity research that has nothing to do with the effect it was named for.
What GILZ is
Glucocorticoid-induced leucine zipper is a protein whose expression is driven by glucocorticoid signalling, and which participates in immune regulation and adipocyte biology. It is a well-characterised downstream effector of the same hormonal system, which is what makes it a reasonable thing to consider alongside a molecule associated with the adrenal axis.
Research material referenced
DSIP 5mg, third-party HPLC tested
Why the question mark matters
The title asks whether these are potential links rather than asserting that they are. That is the correct register for a hypothesis paper, and it is the element most likely to be lost when such work is cited. A proposal in the literature is a suggestion about where to look, not a finding.
What a hypothesis paper contributes
It assembles existing observations into a testable structure. That has real value: it directs subsequent work and identifies what evidence would settle the question. It contributes no new experimental data, and its standing depends entirely on what follows it.
How this fits the wider DSIP picture
It is a further instance of the compound appearing in association with the glucocorticoid and circadian systems rather than with sleep machinery directly. Whether that reflects something real about the molecule, or about what antibodies raised against it detect, is the question running underneath the entire literature.
What is not claimed
Anything about obesity, circadian rhythm, sleep or metabolism in any person. This describes a 2009 hypothesis paper. DSIP holds no marketing authorisation anywhere and material supplied here is for laboratory research only.
Frequently asked questions
Why is DSIP discussed in an obesity review?
The proposed connection runs through glucocorticoids and circadian timing, which link to adipose biology, not through sleep.
How strong is the evidence?
It is a hypothesis paper, and its title ends in a question mark. It assembles existing observations rather than adding new data.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedGimble JM et al., Delta sleep-inducing peptide and glucocorticoid-induced leucine zipper: potential links between circadian mechanisms and obesity? Obes Rev 2009 (PMID 19849801)pubmed.ncbi.nlm.nih.gov
- PubMedBjartell A et al. Horm Res 1991 (PMID 1814802)pubmed.ncbi.nlm.nih.gov
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More DSIP (Delta Sleep-Inducing Peptide) articles
- What the Field Said After Its First DecadeGraf published a DSIP update in Peptides in 1986. Reading a review from the middle of a literature shows what was expected but never arrived.
- The Barrier Any Central Claim Has to CrossA compound said to act on sleep must reach the brain. The blood-brain barrier excludes most peptides, and getting across is an engineering problem.
- What Is DSIP? The Nonapeptide Named for an EEG EffectDSIP is a nonapeptide isolated from rabbit blood in 1977 and named for an observed EEG effect. No gene, precursor or receptor has ever been identified.
- Does DSIP Actually Induce Sleep? What the Evidence ShowsDSIP is named for a sleep effect. The evidence has never firmed up: no gene, no receptor, and a literature its own reviewers call an unresolved riddle.
- How DSIP Was DiscoveredSchoenenberger and Monnier stimulated a sleeping rabbit's thalamus, collected the blood draining from its brain and isolated a peptide. The 1977 method.